Company Profile
Profil emiten IDX — keuangan, direksi, komisaris, anak usaha
PT Phapros Tbk
PEHA
Sector: Healthcare
Industry: Pharmaceuticals
Sub Sector: Pharmaceuticals & Health Care Research
Sub Industry: Pharmaceuticals
Live quote
tidak tersedia
tidak tersedia
Highlight Keuangan (2026 Q2) (In Rp)
EPS
36
ROE
7,19%
ROA
2,11%
Book Value
507
Net Income
15,29 M
Total Sales
482,85 M
Total Assets
1,45 T
DER
2.38x
Struktur Pemegang Saham (>1%)
Free Float Information
Saham tersebar di publik
29,97%
10,56%
Tentang Perusahaan
PT Phapros Tbk was established under the name of N.V. Pharmaceutical Processing Industries, in short N.V. Phapros, based on Notarial Deed No 54 of Tan A Sioe dated 21 June 1954, which later became PT Pharmaceutical Processing Industries, in short PT Phapros based on Notarial Deed No.43 of E. Pondaag, replacing R.M. Soerojo, dated 5 September 1995, which finally became PT Phapros based on Notarial Deed No. 48 of Prof. Dr. Liliana Tedjosaputro, S.H., M.H., MM., dated 12 April 2006. The Company’s immediate and ultimate parent entity is PT Rajawali Nusantara Indonesia, incorporatedand domiciled in Indonesia.
Produk & Lini Bisnis
The company is engaged in pharmaceuticals, health care industry and non-electromedical medical devices.
Dewan Direksi
IR
Ida Rahmi Kurniasih
Director
YR
Yudhi Rangkuti
Director
MJ
Maraja Jeson Siregar
Director
Dewan Komisaris
MR
Maxi Rein Rondonuwu
President Commissioner
MA
Masrizal Achmad Syarief
Commissioner
CA
Chrisma Aryani Albandjar
Independent Commissioner
BW
Bimo Wijayanto
Independent Commissioner
Anak Usaha & Afiliasi
| Nama | Domisili | % |
|---|---|---|
| % |
Trend Keuangan (5 periode terakhir)
— hover bar untuk detail
Total Sales
Net Income (+)
Net Income (-)
2025 Q2
EPS 6
ROE 1,25%
2025 Q3
EPS 12
ROE 2,65%
2025 Q4
EPS 33
ROE 6,76%
2026 Q1
EPS 7
ROE 1,47%
2026 Q2
EPS 36
ROE 7,19%
Laporan Keuangan Historis (5 Periode Terakhir) (In Rp)
| Periode | Total Sales | Net Income | Total Assets | Total Equity | EPS | ROE | DER |
|---|---|---|---|---|---|---|---|
| 2026 Q2 | 482,85 M | 15,29 M | 1,45 T | 425,61 M | 36 | 7,19% | 2.38x |
| 2026 Q1 | 221,09 M | 1,53 M | 1,43 T | 416,05 M | 7 | 1,47% | 2.41x |
| 2025 Q4 | 940,88 M | 28,03 M | 1,39 T | 414,52 M | 33 | 6,76% | 2.32x |
| 2025 Q3 | 683,58 M | 7,74 M | 1,46 T | 389,75 M | 12 | 2,65% | 2.70x |
| 2025 Q2 | 458,23 M | 2,38 M | 1,46 T | 382,13 M | 6 | 1,25% | 2.78x |
Trend Harga Penutupan & Book Value — hover titik untuk detail
Close Price
Book Value
2025 Q2
Close 322
BV 455
ROA 0,33%
2025 Q3
Close 326
BV 464
ROA 0,71%
2025 Q4
Close 300
BV 493
ROA 2,02%
2026 Q1
Close 260
BV 495
ROA 0,43%
2026 Q2
Close 232
BV 507
ROA 2,11%
History Harga Penutupan & Book Value
| Tahun | Qrt | Close Price (Rp) | Book Value (Rp) | ROA |
|---|---|---|---|---|
| 2026 | 2 | 232 | 507 | 2,11% |
| 2026 | 1 | 260 | 495 | 0,43% |
| 2025 | 4 | 300 | 493 | 2,02% |
| 2025 | 3 | 326 | 464 | 0,71% |
| 2025 | 2 | 322 | 455 | 0,33% |
Data diperbarui pada: 2026-09-03 16:32:15